Impact BioMedical, Inc. (IBO) is a publicly traded Healthcare sector company. As of May 21, 2026, IBO trades at $0.53 with a market cap of $58.04M and a P/E ratio of -1.52. IBO moved +4.03% today. Year to date, IBO is +3.30%; over the trailing twelve months it is -3.03%. Its 52-week range spans $0.36 to $6.17. Rallies surfaces IBO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded IBO stock?
Rallies tracks politician and congressional stock disclosures for IBO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Macko Todd D sold 43.40K (~$24.37K) on Mar 27, 2026.
Macko Todd D sold 1.60K (~$961.28) on Mar 25, 2026.
Grady Jason sold 50.00K (~$32.51K) on Mar 23, 2026.
IBO Analyst Consensus
IBO analyst coverage data. Average price target: $0.00.
Common questions about IBO
Which politicians traded IBO stock?
Rallies tracks politician and congressional stock disclosures for IBO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in IBO?
Yes. Rallies tracks politician and congressional stock disclosures for IBO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is IBO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBO. It does not provide personalized investment advice.
